BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6180376)

  • 1. [Interferon].
    Béládi I
    Orv Hetil; 1982 Jun; 123(24):1471-7. PubMed ID: 6180376
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon: an early evaluation.
    McCredie KB; Moore MS
    J Indiana State Med Assoc; 1980 Sep; 73(9):576-8. PubMed ID: 6158538
    [No Abstract]   [Full Text] [Related]  

  • 3. [Update on the use of interferons in clinical practice].
    Lauta VM
    Clin Ter; 1995; 146(6-7):393-448. PubMed ID: 7586995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interferon].
    Vargas Vorackova F; Mata Mendoza JM
    Rev Invest Clin; 1981; 33(4):419-25. PubMed ID: 6173909
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interferon--the prospects and problems of its use in therapeutic and oncological practice].
    Poverennyĭ AM
    Med Radiol (Mosk); 1983 Jun; 28(6):67-71. PubMed ID: 6191171
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interferon].
    Steenhoek A
    Tijdschr Ziekenverpl; 1980 Aug; 33(16):768-70. PubMed ID: 6158137
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interferon 1981: hopes and realities (author's transl)].
    Content J
    Rev Med Brux; 1981 Apr; 2(4):399-404. PubMed ID: 6170102
    [No Abstract]   [Full Text] [Related]  

  • 8. Early days in interferon research.
    Chany C
    Biochimie; 2007; 89(6-7):721-2. PubMed ID: 17573176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel interferons for treatment of hepatitis C virus.
    Clark V; Nelson DR
    Clin Liver Dis; 2009 Aug; 13(3):351-63. PubMed ID: 19628153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interferons: physiology, pharmacology and pharmacotherapeutic perspectives].
    Billiau A
    J Pharmacol; 1983; 14 Suppl 3():105-16. PubMed ID: 6200731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of interferon therapy in treatments for hepatitis C virus-related hepatocellular carcinoma].
    Kubo S; Nishiguchi S; Hirohashi K; Tanaka H; Shuto T; Takemura S; Shiomi S; Kinoshita H
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):1975-9. PubMed ID: 11791377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The drug of first choice: interferon. Clinical pharmacological principles].
    Del Vecchio S; Dianzani F
    Minerva Gastroenterol Dietol; 1995 Mar; 41(1):81-7. PubMed ID: 7542487
    [No Abstract]   [Full Text] [Related]  

  • 13. Significance of the interferon (IFN) in the therapy.
    Mahmutović S; Beslagić E
    Bosn J Basic Med Sci; 2004 Oct; 4(4):42-4. PubMed ID: 15628995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-tumor effects of interferon (author's transl)].
    Sun Y
    Zhonghua Yi Xue Za Zhi; 1981 Sep; 61(9):556-8. PubMed ID: 6176299
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferons: biochemistry and mechanisms of action.
    Tyring SK
    Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 2):1350-3. PubMed ID: 7537022
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiviral chemotherapy and interferon.
    Br Med Bull; 1985 Oct; 41(4):307-405. PubMed ID: 2413947
    [No Abstract]   [Full Text] [Related]  

  • 17. [The kaleidoscopic interferon system].
    Weimar W
    Ned Tijdschr Geneeskd; 1981 May; 125(22):885-9. PubMed ID: 6165901
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of action of interferon and ribavirin in treatment of hepatitis C.
    Feld JJ; Hoofnagle JH
    Nature; 2005 Aug; 436(7053):967-72. PubMed ID: 16107837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interferon against cancer?].
    Gallmeier WM
    MMW Munch Med Wochenschr; 1980 Sep; 122(37):1261-4. PubMed ID: 6158683
    [No Abstract]   [Full Text] [Related]  

  • 20. Can interferon prolong life?
    Esteban R
    Hepatology; 2003 Aug; 38(2):292-4. PubMed ID: 12883472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.